Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine approaches to prevent tuberculosis.

H G Wiker1, T Mustafa, H Målen

  • 1Section for Microbiology and Immunology, The Gade Institute, Armauer Hansen Building, University of Bergen, NO-5021 Bergen, Norway. harald.wiker@gades.uib.no

Scandinavian Journal of Immunology
|August 22, 2006
PubMed
Summary

Developing new tuberculosis (TB) vaccines is crucial due to BCG vaccine failures and drug resistance. Novel vaccines should target Mycobacterium tuberculosis strategies, like macrophage apoptosis inhibition, for better protection, especially in HIV-infected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of extrapulmonary TB on patient quality of life and recurrence.

Public health action·2024
Same author

Care-seeking pathways and diagnostic delays in extrapulmonary TB patients.

Public health action·2023
Same author

Parental TB associated with offspring asthma and rhinitis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Primary drug resistance in extra-pulmonary tuberculosis: a hospital-based prospective study from Pakistan.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Effects of Indomethacin on Active Ion Transport Across the Gills of the Shore Crab, Carcinus maenas.

The Biological bulletin·2018
Same author

Prospective analysis of the sealing ability of the ENSEAL<sup>®</sup> G2 Articulating Tissue Sealer and transector on human mesenteric vessels in colorectal surgery.

Techniques in coloproctology·2017

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major global infectious disease and a significant factor in poverty.
  • Current BCG vaccines show limited efficacy in endemic areas, and rising multi-drug-resistant TB necessitates improved preventative strategies.
  • Effective post-exposure vaccines could prevent 30-40% of TB cases and are vital for protecting HIV-infected individuals.

Purpose of the Study:

  • To investigate novel secreted proteins of Mycobacterium tuberculosis H37Rv for potential vaccine development.
  • To understand Mycobacterium tuberculosis strategies for immune evasion, particularly the inhibition of macrophage apoptosis.
  • To guide the development of new vaccines by considering key regulators of apoptosis, such as FasL and Bcl-2.

Related Experiment Videos

Main Methods:

  • Proteomic characterization of Mycobacterium tuberculosis H37Rv to identify novel secreted proteins.
  • Investigation of these proteins in mouse models to study latent and slowly progressive TB.
  • Analysis of central markers of apoptosis regulation, including FasL and Bcl-2, in the context of TB immunity.

Main Results:

  • Identification of numerous novel secreted proteins from M. tuberculosis H37Rv.
  • Understanding of Mycobacterium tuberculosis's strategy to inhibit macrophage apoptosis for immune evasion.
  • Highlighting the importance of FasL and Bcl-2 in regulating the immune response to TB.

Conclusions:

  • Novel secreted proteins of M. tuberculosis warrant further investigation for vaccine development.
  • Targeting the inhibition of macrophage apoptosis is a promising strategy for new TB vaccines.
  • Considering apoptosis regulators like FasL and Bcl-2 is essential for developing effective TB vaccines against reactivation and in vulnerable populations.